{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:44:28Z","timestamp":1793965468837,"version":"4.8.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871389"],"award-info":[{"award-number":["81871389"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-82521-5","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T23:45:08Z","timestamp":1735343108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Predictive factors influencing hypothyroidism following the radioactive iodine treatment of Graves\u2019 disease in different periods"],"prefix":"10.1038","volume":"14","author":[{"given":"Aomei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueni","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,28]]},"reference":[{"key":"82521_CR1","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0140-6736(16)00278-6","volume":"388","author":"S De Leo","year":"2016","unstructured":"De Leo, S., Lee, S. Y. & Braverman, L. E. Hyperthyroidism. Lancet. 388, 906\u2013918 (2016).","journal-title":"Lancet"},{"issue":"6","key":"82521_CR2","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1210\/er.2002-0020","volume":"24","author":"BS Prabhakar","year":"2003","unstructured":"Prabhakar, B. S., Bahn, R. S. & Smith, T. J. Current perspective on the pathogenesis of Graves\u2019 disease and ophthalmopathy. Endocr. Rev. 24(6), 802\u2013835 (2003).","journal-title":"Endocr. Rev."},{"issue":"2","key":"82521_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.5603\/NMR.2015.0026","volume":"18","author":"K Prasek","year":"2015","unstructured":"Prasek, K., Plazinska, M. T. & Krolicki, L. Diagnosis and treatment of Graves\u2019 disease with particular emphasis on appropriate techniques in nuclear medicine. General state of knowledge. Nucl. Med. Rev. 18(2), 110\u2013116 (2015).","journal-title":"Nucl. Med. Rev."},{"issue":"6","key":"82521_CR4","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/cen.13611","volume":"88","author":"HM Conaglen","year":"2018","unstructured":"Conaglen, H. M., Tamatea, J. A. U., Conaglen, J. V. & Elston, M. S. Treatment choice, satisfaction and quality of life in patients with Graves\u2019 disease. Clin. Endocrinol. 88(6), 977\u2013984 (2018).","journal-title":"Clin. Endocrinol."},{"issue":"5","key":"82521_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrendo.2018.18","volume":"14","author":"PN Taylor","year":"2018","unstructured":"Taylor, P. N. et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat. Rev. Endocrinol. 14(5), 301\u2013316 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"82521_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen, B. R. et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid Cancer the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid Cancer. Thyroid 26(1), 1\u2013133 (2016).","journal-title":"Thyroid"},{"issue":"2","key":"82521_CR7","first-page":"83","volume":"33","author":"Medicine CsoN","year":"2013","unstructured":"Medicine CsoN. The guide of 131I therapy for Graves\u2019 hyperthyroidism (2013 edition). Chin. J. Nucl. Med. 33(2), 83\u201395 (2013).","journal-title":"Chin. J. Nucl. Med."},{"key":"82521_CR8","doi-asserted-by":"crossref","unstructured":"Nakatake, N., Fukata, S. & Tajiri, J. Prediction of post-treatment hypothyroidism using changes in thyroid volume after radioactive iodine therapy in adolescent patients with Graves\u2019 disease. Int. J. Pediatr. Endocrinol. 14 (2011).","DOI":"10.1186\/1687-9856-2011-14"},{"issue":"1","key":"82521_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2265.1997.d01-1737.x","volume":"46","author":"Y Aizawa","year":"1997","unstructured":"Aizawa, Y. et al. The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves\u2019 disease: prevalence, mechanism and prognosis. Clin. Endocrinol. 46(1), 1\u20135 (1997).","journal-title":"Clin. Endocrinol."},{"issue":"1\u20132","key":"82521_CR10","first-page":"9","volume":"178","author":"W-J Zhao","year":"2019","unstructured":"Zhao, W-J., Lv, Q-G., Fei, Y., Zhao, Z. & Zhang, Y-W. Prognostic factors analysis for a calculated dose of I-131 therapy in Graves\u2019 disease in China. Gazz. Med. Italiana Archivio per Le Scienze Mediche. 178(1\u20132), 9\u201318 (2019).","journal-title":"Gazz. Med. Italiana Archivio per Le Scienze Mediche"},{"issue":"3","key":"82521_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1365-2265.1995.tb02039.x","volume":"43","author":"AE Jarlov","year":"1995","unstructured":"Jarlov, A. E., Hegedus, L., Kristensen, L. O., Nygaard, B. & Hansen, J. M. Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while. Clin. Endocrinol. 43(3), 325\u2013329 (1995).","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"82521_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/BF03349519","volume":"13","author":"LJ Degroot","year":"1990","unstructured":"Degroot, L. J., Mangklabruks, A. & McCormick, M. Comparison of RA I-131 treatment protocols for graves-disease. J. Endocrinol. Invest. 13(2), 111\u2013118 (1990).","journal-title":"J. Endocrinol. Invest."},{"issue":"6","key":"82521_CR13","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3109\/02841868009130175","volume":"19","author":"G Lundell","year":"1980","unstructured":"Lundell, G. & Holm, L. E. Hypothyroidism following, I-131 therapy for hyperthyrodism in relation to immunological parameters. Acta Radiol. Oncol. 19(6), 449\u2013454 (1980).","journal-title":"Acta Radiol. Oncol."},{"issue":"3","key":"82521_CR14","first-page":"175","volume":"88","author":"JA Franklyn","year":"1995","unstructured":"Franklyn, J. A., Daykin, J., Holder, R. & Sheppard, M. C. Radioiodine therapy compared in patients with toxic nodular or graves hyperthyroidism. Qjm-Mon J. Assoc. Phys. 88(3), 175\u2013180 (1995).","journal-title":"Qjm-Mon J. Assoc. Phys."},{"issue":"4","key":"82521_CR15","first-page":"1229","volume":"84","author":"O Sabri","year":"1999","unstructured":"Sabri, O. et al. Success rate of radioiodine therapy in Graves\u2019 disease: the influence of thyrostatic medication. J. Clin. Endocr. Metab. 84(4), 1229\u20131233 (1999).","journal-title":"J. Clin. Endocr. Metab."},{"issue":"5","key":"82521_CR16","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1365-2265.2004.02152.x","volume":"61","author":"S Metso","year":"2004","unstructured":"Metso, S. et al. Long-term follow-up study of radioiodine treatment of hyperthyroidism. Clin. Endocrinol. 61(5), 641\u2013648 (2004).","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"82521_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/1450-1147.167582","volume":"15","author":"M Husseni","year":"2016","unstructured":"Husseni, M. The incidence of hypothyroidism following the radioactive iodine treatment of Graves\u2019 disease and the predictive factors influencing its development. World J. Nucl. Med. 15(1), 30\u201337 (2016).","journal-title":"World J. Nucl. Med."},{"issue":"8","key":"82521_CR18","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1001\/jama.1966.03110080045015","volume":"197","author":"MM Nofal","year":"1966","unstructured":"Nofal, M. M. & Beierwal.Wh, Patno, M. E. Treatment of hyperthyroidism with sodium iodide I 131 - a 16-year experience. J. Am. Med. Assoc. 197(8), 605 (1966).","journal-title":"J. Am. Med. Assoc."},{"issue":"6","key":"82521_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/BF03348615","volume":"13","author":"C Marcocci","year":"1990","unstructured":"Marcocci, C. et al. A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of graves hyperthyroidism. J. Endocrinol. Invest. 13(6), 513\u2013520 (1990).","journal-title":"J. Endocrinol. Invest."},{"issue":"12","key":"82521_CR20","first-page":"1528","volume":"123","author":"R-F Wang","year":"2010","unstructured":"Wang, R-F., Tan, J., Zhang, G-Z., Meng, Z-W. & Zheng, W. A comparative study of influential factors correlating with early and late hypothyroidism after I-131 therapy for Graves\u2019 disease. Chin. Med. J-Peking. 123(12), 1528\u20131532 (2010).","journal-title":"Chin. Med. J-Peking"},{"issue":"2","key":"82521_CR21","first-page":"260","volume":"59","author":"LD Marinelli","year":"1948","unstructured":"Marinelli, L. D., Quimby, E. H. & Hine, G. J. Dosage determination with radioactive isotopes practical considerations in therapy and protection. Am. J. Roentgenol. 59(2), 260\u2013281 (1948).","journal-title":"Am. J. Roentgenol."},{"issue":"4","key":"82521_CR22","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/BF00257324","volume":"14","author":"R Wilson","year":"1988","unstructured":"Wilson, R., McKillop, J. H., Black, E., Jenkins, C. & Thomson, J. A. Early prediction of hypothyroidism following I-131 treatment for graves-disease. Eur. J. Nucl. Med. 14(4), 180\u2013183 (1988).","journal-title":"Eur. J. Nucl. Med."},{"issue":"9","key":"82521_CR23","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1118\/1.2964089","volume":"35","author":"L Strigari","year":"2008","unstructured":"Strigari, L. et al. A NTCP approach for estimating the outcome in radioiodine treatment of hyperthyroidism. Med. Phys. 35(9), 3903\u20133010 (2008).","journal-title":"Med. Phys."},{"issue":"2","key":"82521_CR24","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1177\/147323000903700235","volume":"37","author":"GM Shi","year":"2009","unstructured":"Shi, G. M., Xu, Q., Zhu, C. Y. & Yang, Y. L. Influence of propylthiouracil and methimazole pre-treatment on the outcome of iodine-131 therapy in hyperthyroid patients with Graves\u2019 disease. J. Int. Med. Res. 37(2), 576\u2013582 (2009).","journal-title":"J. Int. Med. Res."},{"key":"82521_CR25","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1136\/bmj.39114.670150.BE","volume":"334","author":"MA Walter","year":"2007","unstructured":"Walter, M. A. et al. Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials. Br. Med. J. 334, 514\u2013517 (2007).","journal-title":"Br. Med. J."},{"issue":"1","key":"82521_CR26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12902-020-00557-w","volume":"20","author":"RT Hu","year":"2020","unstructured":"Hu, R. T., Liu, D. S. & Li, B. Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves\u2019 disease patients. BMC Endocr. Disord. 20(1), 76 (2020).","journal-title":"BMC Endocr. Disord"},{"key":"82521_CR27","first-page":"603","volume":"53","author":"R Sankar","year":"2005","unstructured":"Sankar, R., Sekhri, T., Sripathy, G., Walia, R. P. & Jain, S. K. Radioactive iodine therapy in Graves\u2019 hyperthyroidism: a prospective study from a tertiary referral centre in north India. J. Assoc. Physicians India. 53, 603\u2013606 (2005).","journal-title":"J. Assoc. Physicians India"},{"issue":"2","key":"82521_CR28","first-page":"36","volume":"22","author":"MJ Enyi Ejeh","year":"2003","unstructured":"Enyi Ejeh, M. J., Omotayo Ogunjobi, K., Enyi Ejeh, J., Solomon Adedapo, K. & Eniojukan, F. Effectiveness of fixed dose radioactive iodine (RAI) for the treatment of hyperthyroidism: experience of a teaching hospital in South West Nigeria. Mol. Imaging Radionucl. Ther. 22(2), 36\u201341 (2003).","journal-title":"Mol. Imaging Radionucl. Ther."},{"issue":"6","key":"82521_CR29","first-page":"374","volume":"21","author":"D Yaping","year":"2001","unstructured":"Yaping, D., Xianwen, M., Jiang, X. & Huixing, D. Effects of the iodine absorption rate changes in short term in patients with Graves\u2019 hyperthyroidism on the calculated therapeutic dose. Chin. J. Nucl. Med. 21(6), 374 (2001).","journal-title":"Chin. J. Nucl. Med."},{"key":"82521_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/MNM.0000000000000770","volume":"39","author":"D Yang","year":"2018","unstructured":"Yang, D. et al. Prognostic factor analysis in 325 patients with Graves\u2019 disease treated with radioiodine therapy. Nucl. Med. Commun. 39, 16\u201321 (2018).","journal-title":"Nucl. Med. Commun."},{"issue":"5","key":"82521_CR31","doi-asserted-by":"publisher","first-page":"7673","DOI":"10.3892\/mmr.2015.4350","volume":"12","author":"K Guo","year":"2005","unstructured":"Guo, K. et al. Quantitative mRNA expression analysis of selected genes in patients with early-stage hypothyroidism induced by treatment with iodine-131. Mol. Med. Rep. 12(5), 7673\u20137680 (2005).","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"82521_CR32","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.3892\/mmr.2014.3096","volume":"11","author":"W Zhang","year":"2015","unstructured":"Zhang, W. et al. Iodine-131 induces apoptosis in HTori-3 human thyrocyte cell line and G2\/M phase arrest in a p53-independent pathway. Mol. Med. Rep. 11(4), 3148\u20133154 (2015).","journal-title":"Mol. Med. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82521-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82521-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82521-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T14:04:35Z","timestamp":1735394675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82521-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,28]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["82521"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-82521-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,28]]},"assertion":[{"value":"1 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to the retrospective nature of the study, Committee of Medical Research, Xi\u2019an Jiaotong University waived the need of obtaining informed consent and ethic approval. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31148"}}